Gut bacteria may act on the gut-brain axis to alter appetite control and brain function as part of the genesis of eating disorders. The gut-brain axis, connected via neural, hormonal, and immunological pathways, is a bi-directional communication system that is initially recognized for its role in regulating digestive function and food intake.

The study met both primary endpoints with Soliqua demonstrating noninferiority of blood sugar (HbA1c) reduction and superiority on body weight change from baseline compared to premixed insulin. The study also met its key secondary endpoints with Soliqua achieving a greater proportion of people reaching a HbA1c target of <7% without weight gain, a greater proportion of people reaching a HbA1c target of <7% without weight gain and without hypoglycemia, and superiority in reduction of HbA1c compared with those using premixed insulin.

Not only do people with depression have a higher risk of developing type 2 diabetes, people with type 2 diabetes are more likely to develop depression after diagnosis.

Unfortunately, while the A1c differences between the two groups were significantly different at 6, 9, and 12 months after diagnosis, the average A1c level was still at or above 7%, for a considerable proportion of learn about participants. These results underscore the value of CGM use in improving diabetes management in young people, but also demonstrate the require for more effective management strategies in this group.

Walmart has announced a new private brand of analog insulin, the first of its kind, designed to overcome common impediments, like affordability of and access to diabetes care, especially for those without health insurance, according to a Tuesday press release shared on the company's official website. The new plan went into effect this week, and includes FexPen, which goes for $85.88, and analog insulin vials, sold at $72.88. Both products are only available through Walmart's proprietary ReliOn brand, and could save customers up to $101 per vial or $251 per package of FlexPens — a savings of 58% to 75% — read the press release.

It’s stretchable, like a band-aid, waterproof, and long lasting. In today’s Medical Moment, how this small patch may soon take the place of invasive health monitors. For many diabetics, daily monitoring of blood sugar means a finger prick. But what if there was a better way?

Unlike other companies with app-based coaching programs for managing diabetes, such as Livongo and Omada, Virta’s is based on restricting carbohydrates. Users are sent equipment, such as a connected scale, blood glucose and ketone testing strips, and enter their weight and blood sugar data.

The price Americans pay for insulin is more than ten times higher than the average price in 32 other countries combined.

EPFL spin-off Readily3D has developed a novel system that can print biological tissue in just 30 seconds. The firm's technology is being used in a large-scale European project to develop a living model of the pancreas for testing new drugs.

We find that the costs attributed to type 1 diabetes are disproportionately higher than the number of type 1 patients compared with type 2 patients, suggesting that combining the two diseases when estimating costs is not appropriate. This study and another recent contribution provides a necessary first step in estimating the substantial costs of type 1 diabetes on the U.S.

The ams AS7038RB and AS7038GB sensors and AS7030B sensor module, available from Mouser Electronics, are based on photoplethysmography (PPG) and electrocardiogram (ECG), two popular methods for heart rate monitoring (HRM) and heart rate variability (HRV), which measure the pulse rate by sampling light modulated by blood vessels.

The two will collaborate on a new version of Welldoc’s long-running BlueStar diabetes management app, to include dosing data for several insulins produced by Lilly, ahead of the Big Pharma’s future launch of its connected insulin pen.
The BlueStar app has been cleared by the FDA for adults with Type 1 or Type 2 diabetes, offering insulin titration support, a bolus calculator and personalized health coaching. It is designed to integrate with a range of blood sugar readers and continuous glucose monitoring systems.

Biocorp, société française spécialisée dans le développement et la fabrication de dispositifs médicaux et de solutions connectées dans le domaine de la santé, vient d'annoncer la signature de deux nouveaux accords avec le taiwanais Health2Sync et l’espagnol SocialDiabetes. Ces deux partenariats portent sur l’intégration de Mallya, dispositif connecté dédié aux stylos à insuline, aux applications digitales développées par Health2Sync et SocialDiabetes afin d’améliorer la qualité de soins des patients diabétiques.

UK-based digital health start-up Quin has just closed its latest fundraising round, placing its total capital raised to date at £3.6 million. The Quin app provides personalised diabetes treatment information for people who take insulin to manage their blood glucose levels.

FreeStyle Libre 3 is the latest advancement from Abbott’s FreeStyle Libre family of products and featuring the smallest, thinnest continuous glucose monitoring (CGM) sensor (~size of two stacked U.S. pennies) and a more environmentally sustainable system design.

RADIANT plans to screen about 2,000 people with unknown or atypical forms of diabetes that do not fit the common features of type 1 and type 2 diabetes.

Depression is twice as common in people with type 1 or type 2 diabetes as in the general population, and is associated with poor outcomes. Evidence is growing that depression and type 2 diabetes share biological origins, particularly overactivation of innate immunity leading to a cytokine-mediated inflammatory response, and potentially through dysregulation of the hypothalamic-pituitary-adrenal axis. Throughout the life course, these pathways can lead to insulin resistance, cardiovascular disease, depression, increased risk of type 2 diabetes, and increased mortality.

Cecelia Health positively transforms the lives of people living with diabetes and other chronic diseases through our technology enabled personalized digital health solution. Our clinical expert team is comprised of nurses, dietitians, exercise physiologists, certified diabetes care and education specialists, and endocrinologists who are passionate about empowering people with chronic conditions to live rich, healthy, and fulfilling lives. They excel at educating program participants about their condition, motivating better lifestyle choices, and providing the essential problem-solving and emotional support required for people living with chronic conditions.

Although diabetes is life-threatening when left unattended, this disease is highly treatable with the right resources and tools. While lifestyle adjustments and constant vigilance are vital to regulation, individuals diagnosed with diabetes also rely on innovative, state-of-the-art medical treatments and devices to achieve a fulfilling life, free of debilitating health complications.

The integrated system delivers real-time glucose readings, as well as insulin dose information for users to efficiently manage their diabetes. It enables users to see all their information in real-time in one view rather than switching between apps.

Your child with type 1 diabetes is headed back to school. This may be your first go-round with going back to school and juggling child diabetes. Or maybe you’re a pro and just need a checklist. Either way, preparation, communication, and education are pivotal to making sure your child is safe and successful at school. Here are 6 important things to do to prepare your type 1 diabetic for school.

With diabetes, your child generates boatloads of data from insulin doses, to glucose results, carb-to-insulin ratios, A1Cs, and more. Do you have Diabetes Data Overload? Are you feeling overwhelmed by all the data? At times, the data is positive. Other times, it’s downright disheartening or frustratingly unpredictable.

The researchers developed and validated a deep-learning algorithm using nearly 3 million PPG recordings from 53,870 patients. The algorithm impressively managed to correctly identify the presence of diabetes in 82% of patients with diabetes, as well as the absence of diabetes in 97% of patients without diabetes. The algorithm’s performance improved even further when combined with patient data, such as age, gender, and BMI, as well as other co-occurring comorbidities. An additional analysis even showed a correlation between the algorithm’s score and the subjects’ A1c.

The device is being developed via a collaboration between scientists at UCLA, MIT and the University of North Carolina (UNC). It's intended to be adhered to the skin like a band-aid, with a single patch being good for one day of use.

Globally, Type 2 diabetes is on the rise. In 2019 approximately 463 million adults were living with diabetes, and that number is expected to soar to 700 million by 2045, according to the International Diabetes Federation. Type 2 accounts for roughly 90% of all diabetes cases. A majority (79%) of individuals with diabetes are living in low- and middle-income countries, according to the Federation. 

Based out of Zurich, Oviva is a digital health company that helps people with conditions such as obesity, diabetes, and food allergies improve their health with medical, nutritional therapy from professional dietitians.

As you kick off your 2020 year with energy and enthusiasm for improving your overall health, here are a few suggested Dos and Don’ts when it comes to creating those goals.